Debra Ann Fader, MS, LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 106 Avenue C, Matamoras, PA 18336 Phone: 570-877-0488 |
Michele Pizzutti Elliott, M.S., L.P.C., N.C.C. Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1011 Pennsylvania Ave, Matamoras, PA 18336 Phone: 570-961-3361 |
Marina Goldenberg, LPC, LMHC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 102 Riverside Dr Apt 112, Matamoras, PA 18336 Phone: 201-960-2300 |
News Archive
In a first of its kind, Dallas Wiens, a 25 year old construction worker who had suffered severe burns to his head two and a half years ago and lost his face, was given a new face by transplant. Until now he had a face void of features, except for a lipless mouth and a goatee beard. Even his eye sockets were smoothed over with skin taken from other parts of his body. This was after 22 surgical procedures.
The U.S. Food and Drug Administration today finalized a new food safety rule under the landmark, bipartisan FDA Food Safety Modernization Act that will help to prevent wide-scale public health harm by requiring companies in the United States and abroad to take steps to prevent intentional adulteration of the food supply.
A drug approved to treat certain types of cancer has shown promising results in the treatment of patients with scleroderma, according to results from an open-label Phase II trial. While the drug's efficacy must be demonstrated in a Phase III trial, the gold standard for testing a drug, researchers are optimistic that Gleevec- (imatinib) could potentially be a weapon against the chronic connective tissue disease for which a treatment has remained elusive.
Researchers at the National Institute of Neurological Disorders and Stroke have discovered that boosting the transport of mitochondria along neuronal axons enhances the ability of mouse nerve cells to repair themselves after injury.
› Verified 9 days ago